|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/225 | |
| A61K 9/20 | |||
| A61K 31/197 |
| (11) | Patento numeris | 1811986 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05826200.7 |
| Europos patento paraiškos padavimo data | 2005-11-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-08-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-03-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/040127 |
| Data | 2005-11-03 |
| (87) | Numeris | WO 2006/050514 |
| Data | 2006-05-11 |
| (30) | Numeris | Data | Šalis |
| 625737 P | 2004-11-04 | US |
| (72) |
CUNDY, Kenneth, C., US
SASTRY, Srikonda, US
LEUNG, Manshiu, US
KADRI, Balaji, V., US
STACH, Paul, E., US
|
| (73) |
XenoPort, Inc.,
3410 Central Expressway, Santa Clara, CA 95051,
US
|
| (54) | GABAPENTIN PRODRUG SUSTAINED RELEASE ORAL DOSAGE FORMS |
| GABAPENTIN PRODRUG SUSTAINED RELEASE ORAL DOSAGE FORMS |